Related Experiment Video
Updated: May 8, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Probiotic use and prevalence of candidemia and candiduria in a PICU
Suresh Kumar1, Sunit Singhi, Arunloke Chakrabarti
11Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India. 2Department of Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Routine probiotic use in pediatric intensive care units (PICUs) significantly reduced the prevalence of candidemia and candiduria in children receiving broad-spectrum antibiotics. This intervention offers a promising strategy for infection control in vulnerable pediatric populations.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Microbiology
Background:
- Broad-spectrum antibiotics in pediatric intensive care units (PICUs) disrupt the gut microbiota, increasing the risk of fungal infections like candidemia and candiduria.
- Candida species are common causes of nosocomial infections in critically ill children, associated with significant morbidity and mortality.
Purpose of the Study:
- To evaluate the impact of routine probiotic supplementation on the incidence of candidemia and candiduria in pediatric patients receiving broad-spectrum antibiotics.
- To compare fungal infection rates before and after the implementation of a probiotic intervention in a PICU setting.
Main Methods:
- A retrospective
- before and after
- study design was employed in a 12-bed PICU in India.
- The study included children aged 3 months to 12 years who received broad-spectrum antibiotics for over 48 hours.
- Data were collected from a control group (n=376) and a probiotic group (n=344) receiving a specific probiotic mix.
Main Results:
- The probiotic group showed a significantly lower prevalence of candidemia (1.2% vs. 3.7%; p=0.03) and candiduria (10.7% vs. 22%; p=0.0001) compared to the control group.
- Relative risk for candidemia was 0.31 (95% CI, 0.10-0.94) and for candiduria was 0.48 (95% CI, 0.34-0.7) in the probiotic group.
- Trends towards lower rates of nosocomial bloodstream infections and urinary tract infections were observed in the probiotic group, though not statistically significant (p=0.07 and p=0.08, respectively).
Conclusions:
- Routine administration of a probiotic mix can be an effective strategy to decrease the incidence of candidemia and candiduria in pediatric patients on broad-spectrum antibiotics.
- Probiotics may play a role in preventing fungal colonization and subsequent invasive infections in the critically ill pediatric population.
- Further research is warranted to confirm these findings and explore the optimal probiotic formulations and durations for infection prevention in PICUs.
Objectives:
To compare the prevalence of candidemia and candiduria before and after the introduction of routine use of probiotics in children who received broad-spectrum antibiotics in a PICU.
Design:
Retrospective "before and after" study.
Setting:
A 12-bed PICU of a teaching hospital in India.
Patients:
Children 3 months to 12 years old, admitted to the PICU over two 9 months' time periods, who received broad-spectrum antibiotics for more than 48 hours.
Interventions:
Three hundred forty-four patients enrolled between November 2008 and July 2009 after the introduction of routine use of probiotics served as the "probiotic group"; they had received one sachet twice a day of a probiotic mix (EUGI [Wallace Pharma, Goa, India] containing Lactobacillus acidophillus, Lactobacillus rhamnosum, Bifidobacterium longum, Bifidobacterium bifidum, Saccharomyces boulardii, and Streptococcus thermophilus) for 7 days. Three hundred seventy-six children enrolled between February 2007 and October 2007 served as "controls." Blood was sent for bacterial and fungal cultures if clinically indicated and urine catheter/bag specimen was submitted for bacterial and fungal culture twice a week as per unit's protocol.
Measurements And Main Results:
Primary outcome was growth of Candida in blood (candidemia), and secondary outcomes were growth of Candida in urine (candiduria), nosocomial bloodstream infections, and urinary tract infections. Data were retrieved from the case records. Candidemia was seen in four of 344 patients (1.2%) in the probiotic group and in 14 of 376 (3.7%) in the control group (relative risk, 0.31; 95% CI, 0.10-0.94; p = 0.03). Candiduria was noted in 37 of 344 patients (10.7%) in the probiotic group and 83 of 376 (22%) in the control group (relative risk, 0.48; 95% CI, 0.34-0.7; p = 0.0001). The prevalence of nosocomial bloodstream infection and urinary tract infection in the probiotic and control groups was 20.3% and 26% (p = 0.07) and 14.2% and 19.1% (p = 0.08), respectively.
Conclusions:
Routine use of a mix of probiotics in patients who receive broad-spectrum antibiotics could be a useful strategy to reduce the prevalence of candidemia and candiduria in the PICU.
More Related Videos
06:39Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
Published on: September 21, 2015
Related Concept Videos
Endocarditis IV: Nursing Management
Development of the Oral Microbiota
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microbiota of the Urogenital Tract
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care